[1] 冯建华,郑林林,李益民,等.脑转移瘤放射治疗时机的研究进展[J].中华放射肿瘤学杂志,2024,33(4):360~364. [2] 赵永瑞,高莹,陈怡东,等.基于直线加速器的分次立体定向放疗对小体积脑转移瘤的有效性及安全性[J].国际肿瘤学杂志,2023,50(3):138~143. [3] 陈家宇.单发脑转移调强放疗及立体定向放疗对海马的剂量学研究[D].辽宁:大连医科大学,2021. [4] 付小娜,魏涛,赵世杰,等.不同剂量脑立体定向放疗联合PD-1/PD-L1抑制剂治疗非小细胞肺癌脑转移的疗效及安全性[J].实用癌症杂志,2024,39(5):819~822. [5] 中国抗癌协会肿瘤神经病学专业委员会,中国抗癌协会神经肿瘤整合护理专业委员会.脑转移瘤手术指南[J].中华转移性肿瘤杂志,2024,07(4):295~305. [6] Shamseddeen H,Pike F,Ghabril M,et al.Karnofsky performance status predicts outcomes in candidates for simultaneous liver-kidney transplant[J].Clin Transplant,2021,35(2):14190. [7] Ya'Qoub L,Alkhouli M,Elgendy IY.Symptomatic improvement using the New York Heart Association classification as a predictor for survival after transcatheter edge-to-edge repair of the mitral valve[J].Int J Cardiol,2022,353:49~50. [8] 何佳欣,朱小辉,赵小静,等.局部加量调强放疗联合贝伐珠单抗对脑转移瘤患者颅内病灶控制情况的影响[J].医学理论与实践,2024,37(19):3297~3300. [9] Cuccia F,Mazzola R,Figlia V,et al.Stereotactic body radiotherapy for pulmonary oligometastases:amonoinstitutional analysis of clinical outcomes and potential prognostic factors[J].Strahlenther Und Onkol,2022,198(10):934~939. [10] 徐惠,徐利本,吴立广,等.腹主动脉旁预防延伸野放疗联合同步化疗对局部晚期子宫颈癌效果及安全性的影响[J].中国医学创新,2025,22(2):51~56. [11] Makita K,Hamamoto Y,Kanzaki H,et al.Local control of bone metastases treated with external beam radiotherapy in recent years:a multicenter retrospective study[J].Radiat Oncol,2021,16(1):225. [12] 海盼盼,秦玲,温静.自适应调强放疗对局部晚期宫颈癌的治疗效果及安全性[J].实用癌症杂志,2024,39(6):1016~1020. [13] Cummins DD,Morshed RA,Chavez MM,et al.Salvage surgery for local control of brain metastases after previous stereotactic radiosurgery:a single-center series[J].World Neurosurg,2022,158:e323~e333. [14] 袁珂,廖雄飞,王先良,等.容积调强弧形治疗与射波刀六维颅骨追踪技术对头颈部肿瘤晶格空间分割放疗的剂量学研究[J].国际医学放射学杂志,2025,48(1):53~58. [15] Andreou D,Ranft A,Gosheger G,et al.Which factors are associated with local control and survival of patients with localized pelvic Ewing's sarcoma a retrospective analysis of data from the euro-EWING99 trial[J].Clin Orthop Relat Res,2020,478(2):290~302. [16] Klement RJ,Sweeney RA.Metabolic factors associated with the prognosis of oligometastatic patients treated with stereotactic body radiotherapy[J].Cancer Metastasis Rev,2023,42(3):927~940. [17] Makita K,Hamamoto Y,Kanzaki H,et al.Factors affecting survival and local control in patients with bone metastases treated with radiotherapy[J].Med Sci (Basel),2023,11(1):17. |